| scholarly article | Q13442814 |
| P50 | author | Werner Sieghart | Q54281325 |
| Samarpan Majumder | Q104135129 | ||
| P2093 | author name string | Hao Zhou | |
| James M. Cook | |||
| Xiaohui He | |||
| Zhi-Jian Wang | |||
| Jianming Yu | |||
| Shengming Huang | |||
| Joachim Ramerstorfer | |||
| Roman Furtmüller | |||
| Rahul V. Edwankar | |||
| Bryan L. Roth | |||
| Edward M. Johnson | |||
| Bradford D. Fischer | |||
| Stephanie C. Licata | |||
| James K. Rowlett | |||
| P2860 | cites work | Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors | Q46868521 |
| Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. | Q48560999 | ||
| Molecular and neuronal substrate for the selective attenuation of anxiety. | Q51376038 | ||
| Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 | ||
| Effects of different classes of partial benzodiazepine agonists on punished and unpunished responding in pigeons. | Q52175303 | ||
| International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update | Q24608968 | ||
| PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats | Q24644631 | ||
| Type I and type II GABAA-benzodiazepine receptors produced in transfected cells | Q28342945 | ||
| Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors | Q28594296 | ||
| Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates | Q30854476 | ||
| Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. | Q33902217 | ||
| GABA(A) receptor subtypes: dissecting their pharmacological functions | Q34204921 | ||
| Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse. | Q34449375 | ||
| TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. | Q34453763 | ||
| The neurobiology and control of anxious states | Q35202929 | ||
| Overview of diagnosis and drug treatments of anxiety disorders | Q35993517 | ||
| Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models | Q37164117 | ||
| Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors | Q38325476 | ||
| Comparison of drug effects on responding punished by pressurized air or electric shock delivery in squirrel monkeys: pentobarbital, chlordiazepoxide, d-amphetamine and cocaine | Q39661025 | ||
| Which GABAA-receptor subtypes really occur in the brain? | Q41003268 | ||
| Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihyd | Q45248663 | ||
| Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates | Q46723604 | ||
| P433 | issue | 7-8 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 612-618 | |
| P577 | publication date | 2010-08-18 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure | |
| P478 | volume | 59 |
| Q26774869 | A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model |
| Q35158189 | A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia |
| Q45056140 | Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats |
| Q30429949 | Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected]. |
| Q36793359 | Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype |
| Q36421449 | Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis |
| Q30405706 | Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model |
| Q42756275 | Characterization of GABAA receptor ligands with automated patch-clamp using human neurons derived from pluripotent stem cells |
| Q34989652 | Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys |
| Q88692610 | Different Benzodiazepines Bind with Distinct Binding Modes to GABAA Receptors |
| Q37718469 | Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states |
| Q34540561 | Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit |
| Q88548094 | Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys |
| Q38820230 | Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors |
| Q92300503 | GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric Modulators |
| Q30421260 | GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism |
| Q36592958 | HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain |
| Q98287932 | Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic Pain |
| Q38924891 | Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024. |
| Q36775238 | Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys |
| Q40165591 | Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. |
| Q36487793 | Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomes |
| Q30647960 | Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling |
| Q37718608 | Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects |
| Q40819756 | Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy |
| Q98288525 | Synthesis of chiral GABAA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression |
| Q27026637 | The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia |
| Q36128349 | Tonic Inhibitory Control of Dentate Gyrus Granule Cells by α5-Containing GABAA Receptors Reduces Memory Interference |
| Q61449922 | Zolpidem Activation of Alpha 1-Containing GABA Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
Search more.